Login

Diallyl Trisulfide

CAT:
804-HY-117235-01
Size:
25 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Diallyl Trisulfide - image 1

Diallyl Trisulfide

  • CAS Number: 2050-87-5
  • UNSPSC Description: Diallyl Trisulfide is an orally active anticancer agent that can be isolated from garlic. Diallyl Trisulfide has the ability to induce apoptosis and exhibits anticancer, anti-inflammatory, antioxidant, and antibacterial activities. Diallyl Trisulfide can be used to study a variety of cancers, including liver, colon and prostate cancer[1][2][3][4].
  • Target Antigen: Apoptosis; Bcl-2 Family; Fungal; Influenza Virus; Interleukin Related; Reactive Oxygen Species; SOD
  • Type: Natural Products
  • Related Pathways: Anti-infection;Apoptosis;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
  • Field of Research: Cancer; Infection; Inflammation/Immunology
  • Assay Protocol: https://www.medchemexpress.com/diallyl-trisulfide.html
  • Purity: 95.0
  • Solubility: DMSO : 100 mg/mL (ultrasonic)
  • Smiles: C=CCSSSCC=C
  • Molecular Weight: 178.34
  • References & Citations: [1]Pu Liu, et al. Diallyl trisulfide (DATS) effectively induced apoptosis of postharvest diseasePenicillium expansum of citrus. Annals of Microbiology. December 2009, Volume 59, Issue 4, pp 675-679.|[2]Li W, et al. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):577-83. |[3]Zhang F, et al. Diallyl trisulfide inhibits naphthalene-induced oxidative injury and the production of inflammatory responses in A549 cells and mice. Int Immunopharmacol. 2015 Dec;29(2):326-333.|[4]Ming L, et al. Antiviral activity of diallyl trisulfide against H9N2 avian influenza virus infection in vitro and in vivo. Virol J. 2021 Aug 19;18(1):171.
  • Shipping Conditions: Blue Ice
  • Storage Conditions: -20°C (Powder, stored under nitrogen)
  • Clinical Information: No Development Reported